These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10974384)

  • 1. Quality assurance in preoperative radiotherapy of rectal cancer: evaluation of a pre-trial dummy-run.
    Widder J; Sedlmayer F; Stanek C; Pötter R
    Radiother Oncol; 2000 Sep; 56(3):341-7. PubMed ID: 10974384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality assurance in the EORTC 22921 trial on preoperative radiotherapy with or without chemotherapy for resectable rectal cancer: evaluation of the individual case review procedure.
    Kouloulias VE; Bosset JF; van Tienhoven G; Davis BJ; Pierart M; Poortmans P;
    Eur J Cancer; 2002 Sep; 38(14):1849-56. PubMed ID: 12204666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality assurance of the PREOPANC trial (2012-003181-40) for preoperative radiochemotherapy in pancreatic cancer : The dummy run.
    Versteijne E; Lens E; van der Horst A; Bel A; Visser J; Punt CJA; Suker M; van Eijck CHJ; van Tienhoven G
    Strahlenther Onkol; 2017 Aug; 193(8):630-638. PubMed ID: 28608305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality assurance of the 22961 EORTC trial. A phase III study of the optimal combination of hormonal adjuvant treatment by LHRH analogue and radiation therapy for the management of locally advanced prostate cancer: the dummy run.
    Kouloulias VE; Giraud JY; Davis BJ; Dusserre A; Zurlo A; Bolla M
    Radiother Oncol; 2004 Oct; 73(1):11-20. PubMed ID: 15465141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality assurance of the EORTC radiotherapy trial 22931 for head and neck carcinomas: the dummy run.
    Valley JF; Bernier J; Tercier PA; Fogliata-Cozzi A; Rosset A; Garavaglia G; Mirimanoff RO
    Radiother Oncol; 1998 Apr; 47(1):37-44. PubMed ID: 9632290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality assurance for a multicenter Phase II study of stereotactic ablative radiotherapy for hepatocellular carcinoma ≤5 cm: a planning dummy run.
    Bae SH; Kim MS; Jang WI; Kim KB; Cho KH; Kim WC; Lee CY; Kim ES; Choi CW; Chang AR; Jo S; Kim JY
    Jpn J Clin Oncol; 2017 Jun; 47(6):535-542. PubMed ID: 28419246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dummy Run of Quality Assurance Program before Prospective Study of Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases from Non-small Cell Lung Cancer: Korean Radiation Oncology Group (KROG) 17-06 Study.
    Chung E; Noh JM; Lee KC; Kim JH; Chung WK; Suh YG; Lee JA; Seol KH; Wu HG; Kim YS; Noh OK; Park JW; Lee DS; Lee J; Kim YS; Park WY; Kang MK; Jo S; Ahn YC
    Cancer Res Treat; 2019 Jul; 51(3):1001-1010. PubMed ID: 30322229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer.
    Duthoy W; De Gersem W; Vergote K; Boterberg T; Derie C; Smeets P; De Wagter C; De Neve W
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):794-806. PubMed ID: 15465196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.
    Myerson RJ; Valentini V; Birnbaum EH; Cellini N; Coco C; Fleshman JW; Gambacorta MA; Genovesi D; Kodner IJ; Picus J; Ratkin GA; Read TE
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1299-308. PubMed ID: 11483342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality assurance of the EORTC radiotherapy trial 22863 for prostatic cancer: the dummy run.
    Dusserre A; Garavaglia G; Giraud JY; Bolla M
    Radiother Oncol; 1995 Sep; 36(3):229-34. PubMed ID: 8532911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dummy run of quality assurance program in a phase 3 randomized trial investigating the role of internal mammary lymph node irradiation in breast cancer patients: Korean Radiation Oncology Group 08-06 study.
    Chung Y; Kim JW; Shin KH; Kim SS; Ahn SJ; Park W; Lee HS; Kim DW; Lee KC; Suh HS; Kim JH; Shin HS; Kim YB; Suh CO
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):419-26. PubMed ID: 25636764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class solutions for conformal external beam prostate radiotherapy.
    Khoo VS; Bedford JL; Webb S; Dearnaley DP
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):1109-20. PubMed ID: 12605991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison.
    De Meerleer GO; Vakaet LA; De Gersem WR; De Wagter C; De Naeyer B; De Neve W
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):639-48. PubMed ID: 10837946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality assurance of the SCOPE 1 trial in oesophageal radiotherapy.
    Wills L; Maggs R; Lewis G; Jones G; Nixon L; Staffurth J; Crosby T;
    Radiat Oncol; 2017 Nov; 12(1):179. PubMed ID: 29141663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of three different CT simulation and planning procedures for the preoperative irradiation of operable rectal cancer.
    Borger JH; van den Bogaard J; de Haas DF; Braeken AP; Murrer LH; Houben RM; Lammering G
    Radiother Oncol; 2008 Jun; 87(3):350-6. PubMed ID: 18453024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative radiotherapy in rectal carcinoma--aspects of acute adverse effects and radiation technique.
    Frykholm GJ; Isacsson U; Nygård K; Montelius A; Jung B; Påhlman L; Glimelius B
    Int J Radiat Oncol Biol Phys; 1996 Jul; 35(5):1039-48. PubMed ID: 8751414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicentre quality assurance of intensity-modulated radiation therapy plans: a precursor to clinical trials.
    Williams MJ; Bailey M; Forstner D; Metcalfe PE
    Australas Radiol; 2007 Oct; 51(5):472-9. PubMed ID: 17803801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of the effects of belly board and bladder distension in postoperative radiotherapy of rectal cancer patients.
    Kim TH; Kim DY; Cho KH; Kim YH; Jung KH; Ahn JB; Chang HJ; Kim JY; Choi HS; Lim SB; Sohn DK; Jeong SY
    Strahlenther Onkol; 2005 Sep; 181(9):601-5. PubMed ID: 16170488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Planning target volume margin evaluation and critical structure sparing for rectal cancer patients treated prone on a bellyboard.
    Cranmer-Sargison G; Kundapur V; Park-Somers E; Andreas J; Vachhrajani H; Sidhu NP
    Clin Oncol (R Coll Radiol); 2013 Mar; 25(3):e17-22. PubMed ID: 22925598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective MRI-based imaging study to assess feasibility of proton therapy for post-prostatectomy radiation.
    Swisher-McClure S; Yin L; Rosen M; Batra S; Berman AT; Both S; Vapiwala N
    Acta Oncol; 2016 Jul; 55(7):828-33. PubMed ID: 27145164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.